People: AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

19 Jul 2019
Change (% chg)

$-0.34 (-1.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Groves, Regina 

Ms. Regina E. Groves is Independent Director of the AtriCure Inc. Ms. Groves was most recently the Chief Executive Officer at REVA Medical, Inc., a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications from 2015 to March 2019. Prior to joining REVA Medical, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic, Inc., a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Afib ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, Afib ablation. Additionally, Ms. Groves successfully acquired and integrated companies, completed numerous clinical trials and launch novel products in the United States and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic’s Cardiac Rhythm Disease Management (CRDM) business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006. Ms. Groves holds a B.S. in Pharmacy from the University of Florida and an M.B.A. from Harvard Graduate School of Business Administration.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 249,990
Long-Term Incentive Plans, USD --
All Other, USD 66,957
Fiscal Year Total, USD 316,947

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Scott Drake


Michael Carrel


Andrew Wade


Douglas Seith


Justin Noznesky


Salvatore Privitera

As Of  31 Dec 2018